Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQT study of pemafibrate in healthy subjects
NCT02073084Phase 1Completed
- Start
- Jan 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of pemafibrate in dyslipidemia (4 arms). Primary endpoint: Individual Corrected QT Interval duration. Started Jan 2014; status: completed.
02
Drugs
pemafibrate
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02073084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02073084.